ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 50273 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 50273; 2) Community: the network communities that were significantly associated with the response to NSC 50273; 3) Molecule: the relationships between components within communities and NSC 50273; 4) MDR: the compounds that were significantly associated with the NSC 50273.

NSC Compound Enrichment Correlation
NSC 726768 5,6-Dihydro-6-[(4-tert-butyloxycarbonylamino)-1-butyl]-5,11- dioxo-11H-indeno[1,2-c]isoquinoline 0.0137568419586474 0.37059977
NSC 732317 6,7-dichloro-2-methyl-3-(phenylthio)quinoxaline 1,4-dioxide 0.0137568419586474 0.034719614
NSC 741412 4-(5'-bromofuran-2'-yl)-3-bromo-but-3-en-2-one 0.0137568419586474 -0.069612995
NSC 747451 3,19-Benzylidine-14-deoxy-11,12-didehydroandrographolide 0.0137568419586474 -0.043671786
NSC 757306 Pyrimethamine (USAN) 0.0137568419586474 -0.026220484
NSC 176503 Fastigilin B 0.0137568419586476 -0.035887498
NSC 309401 2H-Pyrrolo[3,2-f]quinazoline-2,4(3H)-diamine, 3-[(3-aminophenyl)methyl]-, dihydrochloride 0.0137568419586476 0.036725215
NSC 33530 Null 0.0137568419586476 0.015495958
NSC 352330 Bis(helenalinyl)glutarate 0.0137568419586476 -0.049753324
NSC 382002 Null 0.0137568419586476 -0.02222852
Total:106  Current:42    [First] [Prev] [Next] [Last]